- Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL) Feb 23 STOCKHOLM – February 23, 2023 – Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement... read more
- Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Analysis for Diabetic Gastroparesis Patients Treated with GIMOTI® Versus Oral Metoclopramide at the Digestive Disease Week Plenary Session Feb 23 SOLANA BEACH, Calif., and CHICAGO, IL., February 21, 2023 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 20 NASP is pleased to shine a bright light this week on Perigon Pharmacy 360, the third... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 13 NASP is pleased to shine a bright light this week on Genentech, the second corporate member... read more
- NASP hosts CLE Webinar for Healthcare Attorneys Feb 09 NASP is pleased to announce that it will host a one-hour webinar on legal ethics for... read more
- NASP Urges Participation in the 2023 SPCB Job Analysis Survey Feb 07 The National Association of Specialty Pharmacy (NASP) is urging its members and all industry stakeholders to... read more
- Listen to the NASP Post Show Podcasts Feb 06 Whether you attended the NASP 2022 Annual Meeting & Expo or are just curious about our... read more
- Spotlight: Corporate Member of the Month, February 2023 Feb 06 NASP is pleased to shine a bright light this week on Shipment Trackers, the first corporate... read more
- Spotlight: Corporate Members of the Month, February 2023 Feb 01 NASP is pleased to announce the February Spotlight: NASP Corporate Members of the Month! This month, we’ll... read more
- Spotlight: Corporate Member of the Month, January 2023 Jan 30 NASP is pleased to shine a bright light this week on Optum Frontier Therapies, the fourth... read more